Reflecting on 2024: A Year of Growth, Innovation, and Partnership at Pillar Biosciences
In 2024, Pillar Biosciences made significant strides in advancing our mission of Decision Medicine™ and improving cancer diagnostics through rapid, innovative Next-Generation Sequencing (NGS) kitted solutions. We’ve made substantial advancements and improved access to precision oncology solutions globally. Here is a summary of select key achievements in 2024: FDA Approval of oncoReveal® CDx In April, Pillar […]